New Focus in Project Portfolio of Gerresheimer Subsidiary Sensile Medical

Tuesday, November 19, 2019 Drug News
Email Print This Page Comment bookmark
Font : A-A+

- SQ Innovation and Gerresheimer sign partnership for micro pumps for heart failure treatment

DUSSELDORF, Germany, Nov. 19, 2019 /PRNewswire/ -- Sensile Medical, a subsidiary of Gerresheimer AG, has signed a contract with the Swiss biopharma­ceutical company SQ Innovation AG for the development, market launch and mass production of a micro pump for the treatment of edema in heart failure. Sanofi, on the other hand, has terminated the project with Sensile Medical to develop a micro pump for delivery of insulin to treat diabetes.

"Our micro pump technology is highly advanced and very competitive. It can be used for a variety of treatments across medical conditions. The new SQ Innovation agreement illustrates the attractiveness of our micro pump technology. The pipeline of projects for the micro pump is very promising and we continue to see significant potential in this unique technology," said Dietmar Siemssen, CEO of Gerresheimer AG.

Sensile Medical, a Gerresheimer company, and SQ Innovation AG signed a partnership for the micro pump for the treatment of edema in heart failure for European and American markets. The market launch of the SQ Innovation product is to take place after completion of development and obtaining market authorization. Sensile Medical's micro pump for Parkin­son's treatment has already been approved for the European market in September 2018 and has been launched. A different project, the micro pump for delivery of insulin to treat diabetes, has been terminated by Sanofi for strategic reasons.

Gerresheimer has started several projects with pharma customers for usage of the micro pump in various therapy areas, which illustrate the future potential.

Information about SQ Innovation AG: http://furosemide.com

Gerresheimer AG Klaus-Bungert-Strasse 4 40468 Düsseldorf Germany

Contact: Jens Kürten Group Senior Director Communication & Marketing Phone: +49-211-6181-250 Telefax: +49-211-6181-241 jens.kuerten@gerresheimer.com  www.gerresheimer.com

 

Cision View original content:http://www.prnewswire.com/news-releases/new-focus-in-project-portfolio-of-gerresheimer-subsidiary-sensile-medical-300960929.html

SOURCE Gerresheimer AG



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store